Answers are grounded in this paper and cite their sources.
Preliminary report shows enhanced drug transport in eye drops, suggesting improved drug efficacy.
The eye drop vehicle based on an overloaded pH buffer provides a physiological and significant enhancement of transmucosal and transepithelial transport of cationic substances without inducing ocular tissue damage. This approach may increase drug bioavailability, reduce the required initial dose of active components in dosage forms, decrease toxic burden, and eliminate the need for toxic permeability enhancers in ophthalmic formulations.
No takes yet. Share an insight, caveat, or question.
Kravchik et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: